Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

ERADICATE Hp - Treating Helicobacter Pylori With RHB-105

ClinicalTrials.gov ID: NCT01980095

Public ClinicalTrials.gov record NCT01980095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients

Study identification

NCT ID
NCT01980095
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
RedHill Biopharma Limited
Industry
Enrollment
119 participants

Conditions and interventions

Interventions

  • RHB-105 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2013
Primary completion
May 31, 2015
Completion
Jul 31, 2015
Last update posted
Sep 23, 2019

2013 – 2015

United States locations

U.S. sites
12
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
Anaheim Clinical Trials, LLC Anaheim California 92801
Anaheim Clinical Trials Anaheim California 92801
Catalina Research Institute Chino California 91710
Jupiter Research, Inc. Jupiter Florida 33458
Columbus Regional Research Institute Columbus Georgia 31904
MedPharmics Metairie Louisiana 70006
Investigative Clinical Research Annapolis Maryland 41401
MGG Group Co. Chevy Chase Clinical Research Chevy Chase Maryland 20815
Detroit Clinical Research Center Farmington Hills Michigan 48334
Office of Dr. Stephen Miller, MD Las Vegas Nevada 89144
Peters Medical Research High Point North Carolina 27262
Wake Research Associates Raleigh North Carolina 27612

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01980095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01980095 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →